We work collaboratively with our partners to identify their needs and present opportunities that will ensure the partnership is sustainable, mutually beneficial and will help support the millions of Australians affected by lung disease.
We recognise the importance of working in partnership with all stakeholders who have an interest in lung disease. This includes the pharmaceutical, biotechnology, diagnostic and device industries. Funding from these industries assists the Lung Foundation to achieve its mission and to deliver better outcomes for patients.
It is important, however, for such partnerships to be transparent and able to stand up to scrutiny. For complete transparency, Lung Foundation Australia has created a document defining how we work with pharmaceutical companies and other commercial organisations related to the industry. For the purposes of this document, these companies have been referred to as “Industry”. Read now.
We are incredibly grateful to partner with the following organisations who are committed to enhancing the lives and futures of those affected by lung disease. If you are interested in becoming a corporate partner of Lung Foundation Australia please contact us